# Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity

Study · id `cardio:ct-nct01567774` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01567774](<https://clinicaltrials.gov/study/NCT01567774>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01567774

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT01567774. Randomized; quadruple masking; primary purpose treatment. Start 2012-04 (registry gives no type); primary completion 2014-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT01567774, source copy `cardio:ctgov-nct01567774-2013-05-06`, retrieved 2026-10-26)
- Start date: 2012-04 (registry gives no type) (ClinicalTrials.gov record NCT01567774, source copy `cardio:ctgov-nct01567774-2013-05-06`, retrieved 2026-10-26)
- Primary completion: 2014-03 (anticipated) (ClinicalTrials.gov record NCT01567774, source copy `cardio:ctgov-nct01567774-2013-05-06`, retrieved 2026-10-26)
- Completion: 2015-06 (anticipated) (ClinicalTrials.gov record NCT01567774, source copy `cardio:ctgov-nct01567774-2013-05-06`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT01567774, source copy `cardio:ctgov-nct01567774-2013-05-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01567774-2013-05-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity
- Acronym: PEARL
- Condition: Coronary Artery Disease
- Intervention (Drug): Atorvastatin
- Intervention (Drug): Rosuvastatin
- Lead sponsor: University of Roma La Sapienza
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention name matches this record: Rosuvastatin (`cardio:rosuvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: University of Roma La Sapienza (`cardio:org-university-of-roma-la-sapienza`)

## Provenance

Content hash: 3fd219e7941f51018256e9c6fc97ae11e03b12c8c1371fe2b4a011c008387430
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
